Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bone Biologics (BBLGW) Interest Expenses (2016 - 2017)

Bone Biologics (BBLGW) has disclosed Interest Expenses for 2 consecutive years, with $1.5 million as the latest value for Q4 2017.

  • Quarterly Interest Expenses changed N/A to $1.5 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Dec 2017, up 328.55% year-over-year, with the annual reading at $805109.0 for FY2021, 19.33% down from the prior year.
  • Interest Expenses for Q4 2017 was $1.5 million at Bone Biologics, up from $1.2 million in the prior quarter.
  • The five-year high for Interest Expenses was $1.5 million in Q4 2017, with the low at $310089.0 in Q1 2016.